🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Alessio Cortellini elegantly debating in favor of combo 1L approaches for EGFR NSCLC at #ASCO25 I vote combo 🫡

.Amin Nassar, MD demonstrates that the presence of a detectable, targetable driver alteration in advanced #NSCLC is actionable, regardless of ctDNA variant allelic frequency #ASCO25 Yale Hematology Oncology Fellows Smilow Cancer Hospital Yale School of Medicine Foundation Medicine meetings.asco.org/abstracts-pres…

NSCLC (local/regional) and SCLC oral abstracts start NOW!! #ASCO25 ASCO Rafeh Naqash, MD Patrick Forde and team!

So excited for this session and so proud to see Rafeh Naqash, MD deservedly on the podium leading this session!! Kudos! ASCO #ASCO25

🌟 Come to Poster #249 on Comparative Hepatotoxic AEs with ICIs! This interesting topic is explored by my mentee Nikhil. #Hepatotoxicity #ICIs #ASCO25 Nikhil Vojjala, MD

Had a heartwarming and inspiring conversation with Julie Gralow at the ASCO women’s networking center. Grateful for her time, insights, and the chance to hear about her incredible journey. Leaving #ASCO25 feeling extremely humbled and motivated! ✨

Thanks so much to the organizers for inviting me to this wonderful session! If you missed it @asco, it’s available on demand!! #ASCO25

Really rewarding to spend time in the #asco25 Women’s Networking Center with these future leaders! Sagal Pannu Mamtha Balla, MD, MPH, FACP Sarah Phillips ASCO

Encouraging interim results of the phase 1/2 trial of the HPK1 inhibitor NDI-101150 were presented by David Braun for patients with clear cell renal cell carcinoma (ccRCC) showing promising antitumor activity #ASCO25. Smilow Cancer Hospital OncoAlert meetings.asco.org/abstracts-pres…

This never gets old 😅 It can be #ASCO, it can be #ESMO or #WCLC... Before and after... how on earth are we supposed to get back to clinic without a vacation to recover 😅 David James Pinato 🇺🇦 Rafeh Naqash, MD Giannis Mountzios Alfredo Addeo MD Biagio Ricciuti, MD, PhD Jarushka Naidoo

Truly an #allstar time at #ASCO25. First ever #oral talk was #exhilarating, but more so the quiet moments, the coffee chats☕️, learners eager to grow🌱 and #authentic family. Despite #uncertainty, keep shining your light my fellow #onc stars 🌟 Isabel Preeshagul Anh Lam (she/her)

What an incredible ASCO annual meeting! I am full of renewed purpose, enthusiasm, & ideas! But I am also so happy to be back in #Boston! My new home & the place where so much medical innovation begins! Congrats to all the presenters and attendees! Welcome home! #asco25

Oncologists Arriving at ASCO Returning from ASCO #ASCO25

4 pictures aren’t enough to thank everyone who made this moment possible Sharing an ASCO oral with my co-mentor David Braun and other giants in the field during intern year was surreal Grateful for my Dana-Farber Lank Center for Genitourinary Oncology family, the 💩team, and the one and only Toni Choueiri, MD More

Eid Mubarak to all friends and colleagues celebrating!!

Addressing Physician Barriers to Trial Enrollment: ASCO 2025 Study Published in Nature Reviews Clinical Oncology Charles Jiang MD, MPH Tian Zhang, MD, MHS Ryan Nipp, MD, MPH, FASCO NatureRevClinOncol UTSW Simmons Cancer Center Shaalan Beg MD MBA FASCO oncodaily.com/insight/asco-3… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

Feeling honored to have been invited to speak at the Rural Cancer Conference in Lawrence, Kansas. We discussed Advocacy in Rural America- ✅clinical trial access- 70 percent US counties don’t have access to clinical trials ✅physician shortages- 66 % Rural counties don’t have